Literature DB >> 8555410

Differences in the tumorigenic activity of a pure hydrocarbon and a complex mixture following ingestion: benzo[a]pyrene vs manufactured gas plant residue.

E H Weyand1, Y C Chen, Y Wu, A Koganti, H A Dunsford, L V Rodriguez.   

Abstract

The tumorigenic activity of manufactured gas plant residue (MGP) was evaluated in female A/J mice using a F0927 basal gel diet system. Adulterated diets containing MGP (0.10% or 0.25%) or benzo[a]pyrene (B[alpha]P; 16 or 98 ppm) were fed for 260 days. A negative control group was maintained on a nonadulterated basal gel diet. Mice dosed with a single ip injection of 1.79 mg of B[a]P in a tricaprylin vehicle and maintained on a NIH-07 pellet diet were positive controls. In addition, a nontreated group of mice and a group dosed with vehicle only were maintained on a NIH-07 pellet diet and used as negative controls. Animal body weight and consumption of MGP and B[a]P were monitored throughout the study. Ingestion of a 0.10 or 0.25% MGP adulterated diet resulted in 70 and 100% of the mice developing lung tumors with a multiplicity of 1.19 and 12.17 tumors/mouse, respectively. Mice maintained on a 0.10% MGP diet consumed 0.7 g of MGP containing 1.8 mg of B[a]P while those fed a 0.25% MGP diet ingested 1.5 g of MGP containing 4.2 mg of B[a]P. The incidence of lung tumors in mice fed only B[a]P was considerably lower than that observed for animals fed a MGP diet. A diet containing 98 ppm B[a]P produced a significant incidence of tumor-bearing mice with 52% developing lung tumors. The multiplicity observed in these animals, however, was not significant at 0.59 tumors/mouse. A diet containing 16 ppm B[a]P did not produce a significant tumorigenic response in lung. Animals fed a 16 or 98 ppm B[a]P diet consumed a total of 11 and 67 mg of B[a]P, respectively. A single ip dose of B[alpha]P (1.79 mg in 0.25 mL of tricaprylin) resulted in 100% lung tumorigenesis with a multiplicity of 15.79 tumors/mouse. In contrast to observed induction of lung tumors, no forestomach tumors were detected in any animal fed a 0.10 or 0.25% MGP adulterated diet. However, ingestion of a diet containing only 16 or 98 ppm of B[a]P resulted in 20 and 100% of the mice developing forestomach tumors, respectively. The multiplicity for forestomach tumors was 0.24 and 4.22 tumors/mouse, respectively. The incidence of forestomach carcinomas in tumor bearing mice was 8 and 52%, respectively. The ip administration of 1.79 mg of B[a]P resulted in an 83% forestomach tumor incidence having a multiplicity of 1.83 tumors/mouse. Forestomach carcinomas were induced in 34% of the mice exhibiting forestomach tumors. These data indicate that chronic ingestion of MGP- or B[a]P-adulterated diets produces significant differences in the tumorigenic response of female A/J mouse forestomach and lung tissues.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8555410     DOI: 10.1021/tx00049a008

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  9 in total

Review 1.  Polycyclic aromatic hydrocarbons and digestive tract cancers: a perspective.

Authors:  Deacqunita L Diggs; Ashley C Huderson; Kelly L Harris; Jeremy N Myers; Leah D Banks; Perumalla V Rekhadevi; Mohammad S Niaz; Aramandla Ramesh
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2011-10       Impact factor: 3.781

Review 2.  Comparison of toxicogenomics and traditional approaches to inform mode of action and points of departure in human health risk assessment of benzo[a]pyrene in drinking water.

Authors:  Ivy Moffat; Nikolai Chepelev; Sarah Labib; Julie Bourdon-Lacombe; Byron Kuo; Julie K Buick; France Lemieux; Andrew Williams; Sabina Halappanavar; Amal Malik; Mirjam Luijten; Jiri Aubrecht; Daniel R Hyduke; Albert J Fornace; Carol D Swartz; Leslie Recio; Carole L Yauk
Journal:  Crit Rev Toxicol       Date:  2015-01       Impact factor: 5.635

3.  Meat and meat mutagens and risk of prostate cancer in the Agricultural Health Study.

Authors:  Stella Koutros; Amanda J Cross; Dale P Sandler; Jane A Hoppin; Xiaomei Ma; Tongzhang Zheng; Michael C R Alavanja; Rashmi Sinha
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-01       Impact factor: 4.254

4.  Tumors and DNA adducts in mice exposed to benzo[a]pyrene and coal tars: implications for risk assessment.

Authors:  L S Goldstein; E H Weyand; S Safe; M Steinberg; S J Culp; D W Gaylor; F A Beland; L V Rodriguez
Journal:  Environ Health Perspect       Date:  1998-12       Impact factor: 9.031

5.  Comparative transcriptomic analyses to scrutinize the assumption that genotoxic PAHs exert effects via a common mode of action.

Authors:  S Labib; A Williams; C H Guo; K Leingartner; V M Arlt; H H Schmeiser; C L Yauk; P A White; S Halappanavar
Journal:  Arch Toxicol       Date:  2015-09-16       Impact factor: 5.153

6.  Coal tar pitch extract could induce chromosomal instability of human bronchial epithelial cells mediated by spindle checkpoint-related proteins.

Authors:  Peng Zhang; Zhitao Li; Na Wang; Guangcai Duan; Wei Wang; Yanming Feng; Yong Zhao; Lixia Wang; Hansong Zhu; Qiao Zhang; Xiaozhuan Liu; Weidong Wu; Yongjun Wu; Wu Yao; Jing Wang; Yiming Wu; Feifei Feng
Journal:  Oncotarget       Date:  2017-04-11

7.  Macrophages facilitate coal tar pitch extract-induced tumorigenic transformation of human bronchial epithelial cells mediated by NF-κB.

Authors:  Feifei Feng; Yiming Wu; Shaofeng Zhang; Yu Liu; Lijuan Qin; Yongjun Wu; Zhen Yan; Weidong Wu
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240

8.  Application of benzo(a)pyrene and coal tar tumor dose-response data to a modified benchmark dose method of guideline development.

Authors:  D James Fitzgerald; Neville I Robinson; Beverly A Pester
Journal:  Environ Health Perspect       Date:  2004-10       Impact factor: 9.031

9.  Hazard and risk assessment of chemical mixtures using the toxic equivalency factor approach.

Authors:  S H Safe
Journal:  Environ Health Perspect       Date:  1998-08       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.